Intralesional bleomycin.
The use of intralesional bleomycin to treat Bowen's disease of the palm affecting a motor mechanic is presented. Bleomycin in 1% lignocaine was injected at 3-6 week intervals to a cumulative total of 6.35 U. Follow-up at 18 months showed no local recurrence and no long-term adverse events.
Dyall-Smith
D
D
Monash Medical Centre, Clayton, Victoria, Australia.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use*; D001913:Bowen's Disease / Q000175:diagnosis / Q000188:drug therapy*; D018572:Disease-Free Survival; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin